The latest closing stock price for Y-mAbs Therapeutics as of July 16, 2025 is 4.35.
An investor who bought $1,000 worth of Y-mAbs Therapeutics stock at the IPO in 2018 would have $-819 today, roughly -1 times their original investment - a -21.65% compound annual growth rate over 7 years.
The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
The Y-mAbs Therapeutics 52-week high stock price is 16.11, which is 270.3% above the current share price.
The Y-mAbs Therapeutics 52-week low stock price is 3.55, which is 18.4% below the current share price.
The average Y-mAbs Therapeutics stock price for the last 52 weeks is 8.51.
An investor who bought $1,000 worth of Y-mAbs Therapeutics stock at the IPO in 2018 would have $-819 today, roughly -1 times their original investment - a -21.65% compound annual growth rate over 7 years.
The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
The Y-mAbs Therapeutics 52-week high stock price is 16.11, which is 270.3% above the current share price.
The Y-mAbs Therapeutics 52-week low stock price is 3.55, which is 18.4% below the current share price.
The average Y-mAbs Therapeutics stock price for the last 52 weeks is 8.51.